EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

European Journal of Heart Failure

ISSN 1388-9842 · Oxford University Press (OUP)

Neueste Artikel

  1. Bioelectrical impedance analysis and treatment response to dapagliflozin, spironolactone and their combination: a SOGALDI-PEF analysis

    João Pedro Ferreira, Pedro Marques, Cristina Oliveira, Inês Pereira-Sousa, Ana Beatriz Batista, Francisca Saraiva, Jorge S Almeida, Abhinav Sharma, Faiez Zannad, Joana Pimenta, Ricardo Fontes-Carvalho, Adelino Leite-Moreira, Francisco Vasques-Nóvoa, Arsénio Barbosa, Ana Filipa Ferreira, Cátia Costa, Silvia O Diaz, Diogo Santos-Ferreira, Fernando Friões, Cândida Goncalves, João Tiago Guimarães, Marta Leite, Joana Mascarenhas, Maria Inês Matos, Diana Meireles, Catarina Pereira, Pedro Rodrigues, Ana Santos, Gualter Silva, Carla Sousa

    Erschienen: 2026-11-12DOI: 10.1093/ejhf/xuag335

  2. Ventricular arrhythmia–heart failure interaction and mortality in ICD recipients after myocardial infarction

    Mathieu Echivard, Jean-Marc Sellal, John J V McMurray, Chloé Ziliox, Luca Monzo, Zohra Lamiral, Kévin Duarte, Christian De Chillou, Guillaume Baudry, Nicolas Girerd, Eloi Marijon, Pierre Bordachar, Sylvain Ploux, Karim Benali, Christelle Marquié, Clémence Docq, Didier Klug, Romain Eschalier, Baptiste Maille, Jean-Claude Deharo, Dominique Babuty, Thibaud Genet, Estelle Gandjbakhch, Antoine Da Costa, Olivier Piot, Damien Minois, Jean-Baptiste Gourraud, Pierre Mondoly, Philippe Maury, Serge Boveda, Jean-Luc Pasquié, Raphaël Martins, Christophe Leclercq, Charles Guenancia, Gabriel Laurent, Mathieu Becker, Julien Bertrand, Philippe Chevalier, Vladimir Manenti, Maciej Kubala

    Erschienen: 2026-11-06DOI: 10.1093/ejhf/xuag312

  3. Baseline characteristics and utilization of medical therapies in acute hospitalized and chronic heart failure patients enrolled in GRASP-HF: differences between ICARe-HF and Non-ICARe-HF centres

    Ovidiu Chioncel, Gianluigi Savarese, Cecile Laroche, Offer Amir, Mariya Tokmakova, Mathilde Boutard, Antonio Cannata, Hamlet Hayrapetyan, Hans-Eckart Sarnighausen, Noha El Ouafi, Emilie Soriano, Brenda Moura, Lars Lund, Marianna Adamo, Wendy Guillouche, Maurizio Volterani, Bernard Iung, Wilfried Mullens, Marco Metra, O Chioncel, O Amir, M Adamo, A Cannata, L Lund, M Metra, B Moura, G Savarese, M Tokmakova, M Volterrani, S Abir Khalil, H Abu Hantash, T Ahmed Kafafy, J Alali, E Antohi, M Bekbossynova, M Bosevski, T Christodoulides, M Dankova, L Do Doan, M Dupont

    Erschienen: 2026-10-13DOI: 10.1093/ejhf/xuag317

  4. The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial

    Francesco Fioretti, Faiez Zannad, Irina Barash, Stefano Corda, Justin A Ezekowitz, Carolyn S P Lam, Robert J Mentz, Christopher M O’Connor, Inga Bayh, Aiwen Xing, Javed Butler, Angela Romero Zarante, Yenisca Zambrano, Miguel Hominal, Martin Suarez, Ezequiel Vottero, Marcia Lopez, Oscar Montaña, Gloria Cendali, Marisa Vico, Erica Giozzi, Diego Aizenberg, Santiago Coussio, Diego Arakaki, Miriam Gelersztein, Scott McKenzie, Kathryn Stibilj, David Colquhoun, Gemma Macdonald, John Atherton, Lydia Lilwall, Carmine De Pasquale, Simeoni Thomas, Alicia Chan, Denise Healy, Brendan McQuillan, Natalya Beer, Dirk von Lewinski, Viktoria Rausch, Andreas Schober

    Erschienen: 2026-09-15DOI: 10.1093/ejhf/xuag049

  5. Impact of dapagliflozin, spironolactone, and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF

    João Pedro Ferreira, Joana Mascarenhas, Pedro Marques, Luís Mendonça, Abhinav Sharma, Faiez Zannad, Jorge S Almeida, Ricardo Fontes-Carvalho, Joana Pimenta, Adelino Leite-Moreira, Francisco Vasques-Nóvoa, Ana Beatriz Batista, Arsénio Barbosa, Ana Filipa Ferreira, Ana C Oliveira, Ana Santos, Cátia Costa, Cândida Goncalves, Catarina Pereira, Cláudia Teixeira, Carla Sousa, Diana Meireles, Diogo Santos-Ferreira, Francisca Saraiva, Fernando Friões, Gualter Silva, Inês Pereira-Sousa, João Tiago Guimarães, Marta Leite, Maria Inês Matos, Manuela Torrinha, Pedro Rodrigues, Silvia O Diaz

    Erschienen: 2026-09-15DOI: 10.1093/ejhf/xuag117

Jahrgänge

2026 · 2812025 · 4592024 · 3772023 · 3502022 · 3672021 · 3522020 · 3842019 · 2882018 · 3422017 · 2922016 · 2672015 · 1862014 · 2112013 · 2122012 · 1892011 · 2022010 · 2252009 · 1872008 · 2062007 · 2252006 · 1552005 · 1962004 · 1722003 · 1412002 · 1282001 · 1202000 · 5101999 · 71

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.